JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on September 21, 2006; DOI: 10.1124/jpet.106.111971


0022-3565/06/3193-1317-1326$20.00
JPET 319:1317-1326, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.111971v1
319/3/1317    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jacobson, L. H.
Right arrow Articles by Cryan, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jacobson, L. H.
Right arrow Articles by Cryan, J. F.

NEUROPHARMACOLOGY

GABAB(1) Receptor Subunit Isoforms Exert a Differential Influence on Baseline but Not GABAB Receptor Agonist-Induced Changes in Mice

Laura H. Jacobson, Bernhard Bettler, Klemens Kaupmann, and John F. Cryan1

Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland (L.H.J., K.K., J.F.C.); and Institute of Physiology, Department of Clinical-Biological Sciences, Pharmazentrum, University of Basel, Basel, Switzerland (B.B.)

GABAB receptor agonists produce hypothermia and motor incoordination. Two GABAB(1) receptor subunit isoforms exist, but because of lack of specific molecular or pharmacological tools, the relevance of these isoforms in controlling basal body temperature, locomotor activity, or in vivo responses to GABAB receptor agonists has been unknown. Here, we used mice deficient in the GABAB(1a) and GABAB(1b) subunit isoforms to examine the influence of these isoforms on both baseline motor behavior and body temperature and on the motor-incoordinating and hypothermic responses to the GABAB receptor agonists L-baclofen and {gamma}-hydroxybutyrate (GHB). GABAB(1b)–/– mice were hyperactive in a novel environment and showed slower habituation than either GABAB(1a)–/– or wild-type mice. GABAB(1b)–/– mice were hyperactive throughout the circadian dark phase. Hypothermia in response to L-baclofen (6 and 12 mg/kg) or GHB (1 g/kg), baclofen-induced ataxia as determined on the fixed-speed Rotarod, and GHB-induced hypolocomotion were significantly, but for the most part similarly, attenuated in both GABAB(1a)–/– and GABAB(1b)–/– mice. We conclude that L-baclofen and GHB are nonselective for either GABAB(1) receptor isoform in terms of in vivo responses. However, GABAB(1) receptor isoforms have distinct and different roles in mediating locomotor behavioral responses to a novel environment. Therefore, GABAB(1a) and GABAB(1b) isoforms are functionally relevant molecular variants of the GABAB(1) receptor subunit, which are differentially involved in specific neurophysiological processes and behaviors.


Received August 7, 2006; accepted September 20, 2006.

Address correspondence to: John F. Cryan, Senior Lecturer in Pharmacology, School of Pharmacy, Department of Pharmacology and Therapeutics, University College Cork, Cork, Ireland. E-mail: j.cryan{at}ucc.ie




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. M. Bonaventura, P. N. Catalano, A. Chamson-Reig, E. Arany, D. Hill, B. Bettler, F. Saravia, C. Libertun, and V. A. Lux-Lantos
GABAB receptors and glucose homeostasis: evaluation in GABAB receptor knockout mice
Am J Physiol Endocrinol Metab, January 1, 2008; 294(1): E157 - E167.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.